Clinical response: no clinically significant response in mental state · schizophrenia
1 finding from 1 review
Quality of life: no significant change in quality of life/satisfaction medium term (3‐12 months) not reported · schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Satisfaction with treatment · schizophrenia
1 finding from 1 review
Economic outcomes ‐ total costs (12 months) NHS Reference Costs and unit costs · schizophrenia
1 finding from 1 review
Adverse effect: Specific ‐ Death · schizophrenia
It is very uncertain whether NIDOTHERAPY‐ENHANCED STANDARD CARE changes adverse effects ‐ specific ‐ death Number of individual deaths of… compared with STANDARD CARE (very low certainty).
1 finding from 1 review
Prodromal symptoms: transition to psychosis Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes prodromal symptoms: transition to psychosis Long‐term (events) compared with supportive therapy (very low certainty).
1 finding from 1 review
Global state: clinically important change in global state · people in the prodromal stage of psychosis
1 finding from 1 review
Mental state · people in the prodromal stage of psychosis
1 finding from 1 review
Behaviour: clinically important change in behaviour · people in the prodromal stage of psychosis
1 finding from 1 review
Adverse effects: at least one serious adverse event · people in the prodromal stage of psychosis
1 finding from 1 review
Quality of Life Manchester Short Assessment (MANSA) · people in the prodromal stage of psychosis
1 finding from 1 review
Satisfaction and acceptability of treatment (medium term) ‐ leaving the study early · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes satisfaction with treatment: leaving the study early Endpoint data… compared with supportive therapy (very low certainty).
1 finding from 1 review
Suicide · patients with schizophrenia and severe mental illness
INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY showed no clear difference in committed suicide by three years compared with MEDICATION (low certainty).
1 finding from 1 review
Global impression: 1. Not able to be discharged (long term) · patients with schizophrenia and severe mental illness
INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY may leads to higher global impression: 1. Not able to be discharged (long term) compared with MEDICATION (low certainty).
1 finding from 1 review
Global impression: 2. Given medication during 12 months to three years · patients with schizophrenia and severe mental illness
INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY may leads to lower global impression: 2. Given medication during 12 months to three years compared with MEDICATION (low certainty).
2 findings from 1 review
Well‐being and quality of life Personal Wellbeing Index (PWI‐C) . Scale from: 0 to 77 (low = poor) · patients with schizophrenia
It is very uncertain whether horticultural therapy plus standard care changes well‐being and quality of life Personal Wellbeing Index (PWI‐C) .… compared with standard care alone (very low certainty).
1 finding from 1 review
Clinical global response · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Level of functioning · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Physical fitness · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · patients with schizophrenia
It is very uncertain whether horticultural therapy plus standard care changes satisfaction with treatment Leaving the study early compared with standard care alone (very low certainty).
1 finding from 1 review